Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • H1N1 INFECTION IN PREGNANCY; A RETROSPECTIVE STUDY OF FETO-MATERNAL OUTCOME AND IMPACT OF THE TIMING OF ANTIVIRAL THERAPY

    Naser Al-Husban, Dr. Prof., Nathir Obeidat, Dr. Prof., Oqba Al-Kuran, Dr. Prof., Khaled Al Oweidat, Dr. Prof., Faris Bakri, Dr. Prof.
    e2019020
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.020
    2163
    PDF: 1200
    HTML: 304
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    1839
    PDF: 719
    HTML: 2110
    Untitled: 219
    Untitled: 154
    Untitled: 173
    Untitled: 157
    Untitled: 164
    Untitled: 180
    Untitled: 185
  • INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR

    V. De Sanctis
    e2014.074
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.074
    2248
    PDF: 944
    HTML: 26944
  • ROLE OF HEMATOLOGICAL PARAMETERS AS AN INDICATOR OF ACUTE MALARIAL INFECTION IN UTTARAKHAND STATE OF INDIA

    Smita Chandra, Harish Chandra
    e2013009
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.009
    1566
    PDF: 795
    HTML: 5918
  • ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS

    George Petrikkos, Miranda Drogari-Apiranthitou
    e2011012
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.012
    2835
    PDF: 956
    HTML: 7338
  • EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies

    Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah , Azita Azarkeiva, Maryam Naderi , Sara Matin , Asghar Bazrafshan , Zohreh Zahedi , Afshan Shirkavand , Parisa pishdad, Vincenzo De Sanctis
    e2022026
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.026
    1541
    PDF: 723
    HTML: 232
  • INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

    Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene
    e2018029
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.029
    2866
    PDF: 1049
    HTML: 306
  • BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

    Elisa Balletto, Malorzata Mikulska
    e2015045
    2015-07-01
    https://doi.org/10.4084/mjhid.2015.045
    3156
    PDF: 1832
    HTML: 3658
  • END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life

    Dr. Sophia Delicou, Dr Katerina Xydaki, Dr Maria Moraki, Dr Theodoros Aforozis
    e2026015
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.015
    1022
    PDF: 690
    Html: 159
  • ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY

    Tekin Aksu
    e2018045
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.045
    2779
    PDF: 1265
    HTML: 598
  • DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY

    John Norman Greene, Abraham Tareq Yacoub, Dani Thomas, Carol Yuan, Frank Walsh, David Solomon, Skai Schwartz, Arthur Andrews
    e2015002
    2014-12-19
    https://doi.org/10.4084/mjhid.2015.002
    1972
    PDF: 822
    HTML: 2201
    Table 1: 179
    Table 2: 198
    Table 3: 192
    Table 4: 194
    Table 5: 191
    Tble 6: 184
    Cover Letter: 205
    Greene Tab.7: 194
  • DIFFERENTIATION SYNDROME IN PROMYELOCYTIC LEUKEMIA : CLINICAL PRESENTATION, PATHOGENESIS AND TREATMENT

    Eduardo Magalhães Rego, Gil Cunha de Santis
    e2011048
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.048
    3252
    PDF: 1385
    HTML: 3319
  • Coexisting Pulmonary Tuberculosis and Mucormycosis in a Patient with Aplastic Anemia Post Allogenic Stem Cell Transplantion

    Sanjeev Kumar Sharma, Narendra Agrawal, Anjan Mukherjee, Tulika Seth, Pravas Mishra, Immaculata Xess, Manoranjan Mahapatra, Sanjay Sharma
    e2011036
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.036
    1850
    PDF: 705
    HTML: 882
  • GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload

    Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis , Salvatore Di Maio, Christos Kattamis
    e2023006
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.006
    3928
    PDF: 1102
    HTML: 460
  • CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab

    r. Salam Al-Kindi, Isra Al-Busaidi, Anil Pathare
    e2024046
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.046
    1323
    PDF: 1136
    HTML: 121
  • DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA

    Sudhansu Sekhar Nishank
    e2015046
    2015-07-02
    https://doi.org/10.4084/mjhid.2015.046
    1545
    PDF: 788
    HTML: 1485
    Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 180
  • CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

    Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri
    e2024038
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.038
    2585
    PDF: 1193
    HTML: 108
  • CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

    Athanasios Aessopos, Vasilios Berdoukas
    e2009002
    2009-07-18
    1577
    PDF: 485
    HTML: 1441
  • Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias

    Mehran Karimi, Sezaneh Haghpanah , Azita Azarkeivan , Sara Matin, Arash Safaei, Vincenzo De Sanctis
    e2021008
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.008
    1365
    PDF: 472
    HTML: 180
  • COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia

    Yousef Saeed Mohammad Abu Za’ror, Joseph Bagi Suleiman, Fatima Azzahra Delmani, Jehad Farouq Alhmoud, Amer Mohammad Ayasreh, Sarah Ihsan Al-wendawi, Maryam Azlan
    e2026046
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.046
    424
    PDF: 312
    HTML: 23
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    2850
    PDF: 851
    HTML: 6527
    Untitled: 227
    Untitled: 189
    Untitled: 206
    Untitled: 215
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1086
    PDF: 613
    HTML: 4403
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4317
    PDF: 1485
    HTML: 3622
  • Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia

    Oguzhan Sıtkı Dizdar, Faruk Karakeçili, Belkıs Nihan Coskun, Beyza Ener, Rıdvan Ali, Reşit Mıstık
    e2012039
    2012-06-13
    https://doi.org/10.4084/mjhid.2012.039
    1424
    PDF: 849
    HTML: 904
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    2008
    PDF: 1061
    HTML: 1199
  • MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

    Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh
    e2025032
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.032
    843
    PDF: 758
    HTML: 125
  • CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

    omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad
    e2015049
    2015-08-25
    https://doi.org/10.4084/mjhid.2015.049
    1549
    PDF: 883
    HTML: 982
    figures: 182
    table 1: 183
    table2: 182
    table3: 184
  • HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

    Giuseppe Avvisati
    e2011064
    2011-12-19
    https://doi.org/10.4084/mjhid.2011.064
    13262
    PDF: 972
    HTML: 7292
  • NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2

    Mohsen Nakhaei, Zohreh-Al-Sadat Ghoreshi, Mohammad Rezaei Zadeh Rukerd, Hedyeh Askarpour, Nasir
    e2023059
    2023-10-16
    https://doi.org/10.4084/MJHID.2023.059
    963
    PDF: 462
    HTML: 119
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2458
    PDF: 788
    HTML: 1736
  • QUANTITATIVE ANALYSIS OF LIVER IRON DEPOSITION BASED ON DUAL-ENERGY CT IN THALASSEMIA PATIENTS

    Fengming Xu, Cheng Tang, Yiling Huang, Linlin Liang, Fuling Huang, Gaohui Yang, Peng Peng
    e2023020
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.020
    945
    PDF: 906
    HTML: 376
  • MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

    Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi
    e2012032
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.032
    2704
    PDF: 1010
    HTML: 2294
  • How I treat acute and persistent sickle cell pain

    Samir Ballas
    e2020064
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.064
    1940
    PDF: 1119
    HTML: 487
  • MOLECULAR ANALYSIS OF NON-TRANSFUSION DEPENDENT THALASSEMIA ASSOCIATED WITH HEMOGLOBIN E-?-THALASSEMIA DISEASE WITHOUT ?--THALASSEMIA

    Paramee Phanrahan, Supawadee Yamsri, Nattiya Teawtrakul, Goonnapa Fucharoen, Kanokwan Sanchaisuriya, Supan Fucharoen
    e2019038
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.038
    1402
    PDF: 1053
    HTML: 250
  • A MULTICENTRE ICET-A STUDY OF CONFIRMED SARS-COV-2 INFECTION IN PATIENTS WITH HEMOGLOBINOPATHIES: PRELIMINARY DATA FROM 10 COUNTRIES

    Vincenzo De Sanctis
    e2020046
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.046
    2861
    PDF: 1576
    HTML: 308
  • PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?

    Kalliopi Zachou, Pinelopi Arvaniti, Nikolaos K. Gatselis, Kalliopi Azariadis, Georgia Papadamou, Eirini Rigopoulou, George N. Dalekos
    e2017003
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.003
    2940
    PDF: 982
    HTML: 2064
    Cover letter: 179
  • MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

    Ibrahim C. Haznedaroglu
    e2014009
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.009
    3978
    PDF: 1514
    HTML: 9190
    Untitled: 280
    Untitled: 187
    Untitled: 170
    Untitled: 165
    Untitled: 185
    Untitled: 340
  • NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014

    Abraham Tareq Yacoub, Jayasree Krishnan, Ileana M. Acevedo, Joseph Halliday, John Norman Greene
    e2015030
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.030
    2113
    PDF: 993
    HTML: 4073
    Cover Letter: 221
    Figure 1: 235
    Figure 2: 231
    Table 1: 205
  • RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC

    Rawanda Shamoon, Ahmed K. Yassin, Sara L. Alnuaimi
    e2024019
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.019
    1057
    PDF: 1160
    HTML: 79
  • THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL

    Eliezer Rachmilewitz
    e2014022
    2014-03-10
    https://doi.org/10.4084/mjhid.2014.022
    1495
    PDF: 969
    HTML: 2111
  • Takayasu Arteritis Initially Mimicking Infective Endocarditis

    Aytekin Alcelik, Sevim Karacay, Ismail Necati Hakyemez, Busra Akin, Serkan Ozturk, Haluk Savli
    e2011040
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.040
    1269
    PDF: 602
    HTML: 1098
  • EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

    Mehrez Mehrez M. Jadaon
    e2011037
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.037
    3123
    PDF: 809
    HTML: 12902
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2127
    PDF: 879
    HTML: 170
  • TREATMENT OF CANCER IN THE OLDER AGED PERSON

    Lodovico Balducci
    e2010029
    2010-10-01
    https://doi.org/10.4084/mjhid.2010.029
    1187
    PDF: 839
    HTML: 3364
  • CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT

    Ola Khorshid, Amira Diaa, Mohamed Abd El Moaty, Rafat Abd El Fatah, Ihab El Dessouk, Maha Abd El Hamid, Essam El Noshokaty, Ghada El Saied, Tamer M Fouad, Safaa M Ramadan
    e2011060
    2011-12-07
    https://doi.org/10.4084/mjhid.2011.060
    3036
    PDF: 953
    HTML: 2292
  • Clinical spectrum and genotypes of children with alpha-thalassemia in northeastern, Thailand

    Patcharee Komvilaisak, Nattakarn Sangkha, Arunee Jetsrisuparp, Kunanya Suwannaying, Goonnapa Fucharoen, Napat Laoaroon
    e2025081
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.081
    294
    PDF: 209
    Html: 71
  • Sickle Cell Disease: Management options and challenges in developing countries

    Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong
    e2013062
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.062
    2467
    PDF: 1292
    HTML: 1022
  • Clinical Manifestation of Children with Kawasaki Disease during the COVID-19 Pandemic in Iran: A Case Series

    zahra Fotokian
    e2025017
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.017
    851
    PDF: 804
    HTML: 67
  • WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.

    Giorgio La Nasa, Adriana Vacca, Roberto Littera, Eugenia Piras, Sandro Orru, Marianna Greco, Carlo Carcassi, Giovanni Caocci
    e2016048
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.048
    3157
    PDF: 1140
    HTML: 1491
    Untitled: 177
    Untitled: 169
    Untitled: 168
  • ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE

    Lijie Ma, Ling Chen
    e2026034
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.034
    165
    PDF: 204
    Suppl. Files: 33
    HTML: 21
51 - 100 of 213 items << < 1 2 3 4 5 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy